Inventor

GOSSELIN GILLES

FR57 patents

⚠️ This page may combine multiple inventors who share the name “GOSSELIN GILLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GOSSELIN GILLES

IDENIX PHARMACEUTICALS INC

Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infections

3′-prodrugs of 2′-deoxy-β-L-nucleosides

β-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis B

β-L-2′-deoxy-nucleosides for the treatment of hepatitis B

Compounds and pharmaceutical compositions for the treatment of viral infections

2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

3′-prodrugs of 2′-deoxy-β-L-nucleosides

4′-fluoro nucleosides for the treatment of HCV

Compounds and pharmaceutical compositions for the treatment of viral infections

2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections

2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections

3′-deoxy nucleosides for the treatment of HCV

3′,5′-cyclic phosphate prodrugs for HCV infection

Purine nucleoside analogues for treating flaviviridae including hepatitis C

Compounds and pharmaceutical compositions for the treatment of viral infections

β-L-2′-deoxy-nucleosides for the treatment of hepatitis B

β-L-2′-deoxy-nucleosides for the treatment of hepatitis B

UNIV EMORY

Nucleosides with anti-hepatitis B virus activity

Nucleosides with anti-hepatitis B virus activity

Nucleoside with anti-hepatitis B virus activity

β-L nucleosides for the treatment of HIV infection

Treating HBV with phospholipid prodrugs of β-L-2&#39;,3&#39;-dideoxyadenosine 5&#39;-monophosphate

Nucleosides with anti-hepatitis B virus activity

(unassigned)

Acyclovir derivatives as antiviral agents

Phosphotriester oligonucleotides, amidites and method of preparation

Phosphotriester type biologically active compounds

Phosphotriester type biologically active compounds

CENTRE NAT RECH SCIENT

Methods and compositions for treating hepatitis C virus using 4&#39;-modified nucleosides

Biologically active phosphotriester-type compounds

Biologically active phosphotriester-type nucleosides and methods for preparing same

SURLERAUX DOMINIQUE

Compounds and pharmaceutical compositions for the treatment of viral infections

Compounds and pharmaceutical compositions for the treatment of viral infections

Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections

NOVIRIO PHARMACEUTICALS LTD

β-L-2&#39;-deoxy-nucleosides for the treatment of hepatitis B

β-L-2′-deoxy-nucleosides for the treatment of hepatitis B

STORER RICHARD

Modified 2′ and 3′ nucleoside prodrugs for treating flaviviridae infections

Purine nucleoside analogues for treating flaviviridae including hepatitis C

UNIV CAGLIARI

Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

ISIS PHARMACEUTICALS INC

Phosphotriester oligonucleotides, amidities and method of preparation

SOMMADOSSI JEAN-PIERRE

Compounds and pharmaceutical compositions for the treatment of viral infections

UNIV MONTPELLIER II

β-L-2′-deoxy-nucleosides for the treatment of hepatitis B

UAB RESEARCH FOUNDATION

β-L-2&#39;-deoxy-nucleosides for the treatment of HIV infection

SYNTHELABO

Pharmaceutical compositions based on xylosides and lyxosides of purine and pyrimidine bases used in a method of treating viruses

IDENIX PHARMACEUTICALS LLC

3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV

UNIV NEW YORK STATE RES FOUND

9-substituted adenine derivatives as prodrug regulators of cell and tissue function

Treating HBV with phospholipid prodrugs of β-L-2',3'-dideoxyadenosine 5'-monophosphate

Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides

β-L-2'-deoxy-nucleosides for the treatment of hepatitis B

β-L-2'-deoxy-nucleosides for the treatment of HIV infection